Department of Laboratory Diagnostics, Changhai Hospital Affiliate to the Second Military Medical University, Shanghai, China.
J Med Virol. 2010 Jan;82(1):23-31. doi: 10.1002/jmv.21669.
Hepatitis B surface antigen (HBsAg) and anti-HBs antibodies (anti-HBs) may coexist in certain chronic hepatitis B (CHB) patients. This study was designed to further explore the relationship between this coexistence and hepatitis B Virus (HBV) preS deletions. Sera of 28 patients carrying both HBsAg and anti-HBs (Group I) and those of another 28 HBsAg positive but anti-HBs negative patients (Group II) were collected from CHB patients. Direct sequencing of polymerase chain reaction products or sequencing of clones was applied to both groups to determine sequences of HBV preS and S genes. Genotyping of the S gene indicated that all sampled HBVs were either Genosubtype Ba or Genosubtype Ce. Seven samples in Group I harbored HBV preS deletion mutations. Three of the seven samples showed large deletion mutations in 3' terminus of preS1 and co-existence of the mutant type and the full-length wild type, and the remaining four samples showed deletion mutations in 5' terminus of preS2. All mutant strains were found to be genosubtype Ce. Only two samples in Group I showed G145R/A mutation. Only one sample in Group II contained preS deletion mutation. It is therefore concluded that HBV preS deletion mutations are likely to be related to the coexistence of HBsAg and anti-HBs in CHB patients (P-value = 0.024). Some immune reactions may select for the preS deletion in CHB patients with anti-HBs, the possible marker for immune selection.
乙肝表面抗原 (HBsAg) 和抗-HBs 抗体 (抗-HBs) 可能同时存在于某些慢性乙型肝炎 (CHB) 患者中。本研究旨在进一步探讨这种共存与乙型肝炎病毒 (HBV) preS 缺失之间的关系。收集了 28 例同时携带 HBsAg 和抗-HBs 的 CHB 患者 (I 组) 和 28 例 HBsAg 阳性但抗-HBs 阴性的患者 (II 组) 的血清。应用聚合酶链反应产物直接测序或克隆测序分别对两组患者的 HBV preS 和 S 基因序列进行了检测。S 基因的基因分型表明,所有被检测的 HBV 均为基因型 Ba 或基因型 Ce。I 组中有 7 例存在 HBV preS 缺失突变。这 7 例中有 3 例在 preS1 3'末端发生大片段缺失突变,同时存在突变型和全长野生型,其余 4 例在 preS2 5'末端发生缺失突变。所有突变株均为基因型 Ce。I 组中仅有 2 例出现 G145R/A 突变。II 组中仅有 1 例存在 preS 缺失突变。因此,HBV preS 缺失突变可能与 CHB 患者 HBsAg 和抗-HBs 的共存有关 (P 值 = 0.024)。一些免疫反应可能会选择 CHB 患者中的 preS 缺失,这可能是免疫选择的标志。